| 1 | LLY | Eli Lilly and Company | 20.39% |
| 2 | NVSN.MX | Novartis AG ADR | 10.09% |
| 3 | MRK | Merck & Co., Inc. | 8.96% |
| 4 | NVO | Novo Nordisk A/S | 7.40% |
| 5 | BMY | Bristol-Myers Squibb Company | 4.62% |
| 6 | PFE | Pfizer Inc. | 4.59% |
| 7 | JNJ | Johnson & Johnson | 4.38% |
| 8 | AZN | AstraZeneca PLC | 4.37% |
| 9 | GSK | GSK plc | 4.36% |
| 10 | MCK | McKesson Corporation | 4.29% |
| 11 | ABBV | AbbVie Inc. | 4.15% |
| 12 | SNY | Sanofi | 4.14% |
| 13 | COR | Cencora, Inc. | 3.97% |
| 14 | ZTS | Zoetis Inc. | 3.38% |
| 15 | HLN | Haleon plc | 2.85% |
| 16 | TEVA | Teva Pharmaceutical Industries Limited | 2.65% |
| 17 | TAK | Takeda Pharmaceutical Company Limited | 2.60% |
| 18 | VTRS | Viatris Inc. | 0.78% |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 0.59% |
| 20 | AXSM | Axsome Therapeutics, Inc. | 0.46% |
| 21 | ELAN | Elanco Animal Health Incorporated | 0.46% |
| 22 | CORT | Corcept Therapeutics Incorporated | 0.17% |
| 23 | OGN | Organon & Co. | 0.12% |
| 24 | TSX: BHC | Bausch Health Companies Inc. | 0.12% |
| 25 | PRGO | Perrigo Company plc | 0.09% |
| View PPH holdings |
